Global 3D Cell Culture Market to Garner $12,638.8 Million Revenue with 29.4% CAGR by the End of 2026
March 04, 2020 06:16 ET
|
Research Dive
New York, USA, March 04, 2020 (GLOBE NEWSWIRE) -- As per the new Research Dive published report, the global 3D cell culture market is set to grow at a 29.4% CAGR and will generate a revenue of...
Organ Care System Market for Lungs, Expected to Grow at a CAGR of 19% by 2026 - Research Dive
March 03, 2020 07:30 ET
|
Research Dive
New York, USA, March 03, 2020 (GLOBE NEWSWIRE) -- A medical device called the organ care system (OCS) maintains organ viability by providing an artificially regulated environment that stimulates...
Rising Diabetes Cases to Fuel the Growth of Tubeless Insulin Pump Market, Globally
February 27, 2020 08:22 ET
|
Research Dive
New York, USA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- A new report published by Research Dive clarifies, the tubeless insulin pump market is set to grow at a CAGR of 23.4% from 2019 to 2026, globally. It...
Chromatography System Market is to cross $16,014 million by 2026 at a CAGR of 6.6%
February 27, 2020 07:07 ET
|
Research Dive
New York, USA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global chromatography system market is anticipated to reach $16,014.9 million by 2026 at a CAGR...
Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S
January 29, 2020 08:59 ET
|
Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 12/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 29. januar 2020 Offentliggørelse af Nasdaq Copenhagen A/S'...
Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
January 29, 2020 08:59 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 12/2020 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 29 January 2020 Nasdaq Copenhagen A/S has Accepted Veloxis...
Offentliggørelse af Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S
January 24, 2020 11:01 ET
|
Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 10/2020 Til: NASDAQ Copenhagen A/S København, Danmark, fredag den 24. januar 2020 Offentliggørelse af Anmodning om...
Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
January 24, 2020 11:01 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 10/2020 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, Friday 24 January 2020 Announcement of Request...
Meddelelse om Tvangsindløsning til Aktionærerne i Veloxis Pharmaceuticals A/S
January 24, 2020 10:08 ET
|
Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 9/2020 Til: NASDAQ Copenhagen A/S København, Danmark, fredag den 24. januar 2020 Meddelelse om Tvangsindløsning til...
Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
January 24, 2020 10:08 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 9/2020 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, Friday 24 January 2020 Notice on Compulsory Acquisition to the...